News & Analysis on Clinical Trial Services & Contract Research And Development
Immtech International has been issued with a patent for compounds used to control gene expression, which will add to the potential use of Immtech's compounds as small molecule drugs that can control gene expression selectively.
A tuberculosis drug candidate, which has been described as the most promising Tuberculosis (TB) drug in 40 years, may lead to a shorter and more effective treatment.
Scientists have reported the existence of enzyme-inhibiting chemicals that severely hamper Ebola virus reproduction in laboratory-grown cells. The discovery could form a basis for possible drug treatments for Ebola virus infections and hemorrhagic...